Anatara Lifesciences Ltd (ASX:ANR) 2018 Annual Report
Anatara Lifesciences (ASX:ANR) is pleased to release its Annual Report, for the year ended 30th June 2018.
Companies in the News
Biotech
Rhinomed Limited (ASX:RNO) Signs 12-Year Licensing Agreement with America's Largest Medical Cannabis Operator - Columbia Care LLC
Melbourne based nasal respiratory company Rhinomed (ASX:RNO) (OTCMKTS:RHNMF) is pleased to advise investors it has signed a 12-year exclusive licensing agreement of its nasal platform technology with Columbia Care LLC, the largest and most experienced provider of cannabis-based products and services in the United States (U.S.).
Queensland Bauxite Ltd (ASX:QBL) Recompliance Prospectus
Queensland Bauxite Ltd (ASX:QBL) Prospectus has been prepared for an offer of up to 170,000,000 new Shares at an issue price of $0.035 per Share to raise up to $5,950,000, with a minimum subscription of $1,995,000 together with one (1) free attaching Option for every two (2) Shares subscribed for and issued.
Regeneus Ltd (ASX:RGS) Receives R&D Tax Incentive of $2.4M
Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, today reported that it has received $2.4m from the Australian Government's Research and Development tax incentive program for activities conducted during the financial year 2018.
Oventus Medical Ltd (ASX:OVN) Appoints Medical Technology Advisory Board to Guide Commercialisation of Sleep Treatment Platform
Oventus Medical Ltd (ASX:OVN) is pleased to announce the appointment of a Medical Technology Advisory Board of international sleep experts to help guide the development and commercialisation of the Company's Sleep Treatment Platform.
Nanollose Ltd (ASX:NC6) 2018 Annual Report
Nanollose Ltd (ASX:NC6) provides the Company's 2018 Annual Report.
Regeneus Ltd (ASX:RGS) FY18 Results and Business Update
Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, is pleased to provide an overview of its results for the financial year ended 30 June 2018.
◂Previous Page
Biotech Next Page▸
Banking & Finance
- Locksley Resources Limited (ASX:LKY) Qualifies for Trading on U.S. OTCQX Market
- Resolution Minerals Ltd (ASX:RML) OTCQB Listing Successfully Completed
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
Oil Gas & Energy
- Central Petroleum Limited (ASX:CTP) LOI Signed for New Drilling and Long-Term Gas Supply
- Beetaloo Energy Australia Limited (ASX:BTL) Reaches Carpentaria Pilot Project FID
- Beetaloo Energy Australia Limited (ASX:BTL) Final Approval for EP187 Appraisal Gas Sales
- State Gas Limited (ASX:GAS) Secured $3.2 million via Structured Loan Notes at a Premium
- Ellis Martin Report: Desert Mountain Energy and Altech Batteries Sign LOI for New Mexico SNC Battery Plant and REE Project
- Beetaloo Energy Australia Limited (ASX:BTL) Energy Receives Federal Ministerial Approval
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Predicts Risk of DKD in Aboriginal Australians
- TempraMed Technologies Ltd. (CNSX:VIVI) Exclusive Commercial Distribution Agreement with Turkish Medical Device Supplier
- BPH Energy Limited (ASX:BPH) Chair's Address to Shareholders
- Proteomics International Laboratories Ltd (ASX:PIQ) US Medicare Sets Reimbursement Price for PromarkerD DKD Test
- Proteomics International Laboratories Ltd (ASX:PIQ) OxiDx Test Correlates with Superior Racehorse Performance
- Proteomics International Laboratories Ltd (ASX:PIQ) AGM Chair's Address and Company Presentation
Social Media
